Tesamorelin is a synthetic peptide made up of 44 amino acids and acts as an analog of growth hormone-releasing hormone (GHRH). Initially studied for its effectiveness in reducing visceral fat in individuals with HIV-associated lipodystrophy, ical research. Beyond its impact on fat metabolism, Tesamorelin is also being explored for its potential benefits in supporting nerve health and slowing the progression of mild cognitive impairment. Some studies indicate it may be significantly more effective than other currently available therapies for reducing deep abdominal fat, making it a compelling subject of ongoing clin. Tesamorelin has shown promising results in clinical studies, with some findings suggesting up to a 20% reduction in deep abdominal fat among individuals with HIV-associated lipodystrophy.
